The sudden emergence of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)
at the end of 2019 from the Chinese province of Hubei and its subsequent pandemic spread …

Abstract Development of effective preventative interventions against SARS-CoV-2, the
etiologic agent of COVID-19 is urgently needed. The viral surface spike (S) protein of SARS-CoV-…

Cells and mice infected with arthropod-borne flaviviruses produce a small subgenomic RNA
that is colinear with the distal part of the viral 3′-untranslated region (UTR). This small …

Middle East respiratory syndrome coronavirus (MERS-CoV) causes severe respiratory infections
that can be life-threatening. To establish an infection and spread, MERS-CoV, like most …

Systemic immune cell dynamics during coronavirus disease 2019 (COVID-19) are extensively
documented, but these are less well studied in the (upper) respiratory tract, where severe …

Middle East respiratory syndrome coronavirus (MERS-CoV) is a newly emerging human
pathogen that was first isolated in 2012. MERS-CoV replication depends in part on a virus-…

The rapid development of a SARS-CoV-2 vaccine is a global priority. Here, we develop two
capsid-like particle (CLP)-based vaccines displaying the receptor-binding domain (RBD) of …

Safe and effective coronavirus disease–19 (COVID-19) vaccines are urgently needed to
control the ongoing pandemic. While single-dose vaccine regimens would provide multiple …

Previously we have shown that a single dose of recombinant adenovirus serotype 26 (Ad26)
vaccine expressing a prefusion stabilized SARS-CoV-2 spike antigen (Ad26.COV2.S) is …

Yellow Fever (YF) and Lassa Fever (LF) are two prevalent hemorrhagic fevers co-circulating
in West Africa and responsible for thousands of deaths annually. The YF vaccine 17D has …